Jim Barlow Founder of ImmunoGenesis Backed byAdit VenturesEric Munson LinkedIn SourcesImmunoGenesis Doses First Patient in Phase 1a/1b Clinical Trial of IMGS‑001 in Relapsed or Refractory Advanced Solid Tumors — 2024-04 Browse all founders · Browse investors
